Cargando…
Erratum to: Gluten and Aluminum Content in Synthroid(®) (Levothyroxine Sodium Tablets)
Autores principales: | Espaillat, Ramon, Jarvis, Michael F., Torkelson, Cory, Sinclair, Brent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599445/ https://www.ncbi.nlm.nih.gov/pubmed/28856598 http://dx.doi.org/10.1007/s12325-017-0608-6 |
Ejemplares similares
-
Gluten and Aluminum Content in Synthroid(®) (Levothyroxine Sodium Tablets)
por: Espaillat, Ramon, et al.
Publicado: (2017) -
Comparative Effectiveness of Persistent Use of a Name-Brand Levothyroxine (Synthroid®) vs. Persistent Use of Generic Levothyroxine on TSH Goal Achievement: A Retrospective Study Among Patients with Hypothyroidism in a Managed Care Setting
por: Wang, Liya, et al.
Publicado: (2021) -
The Association Between Switching from Synthroid(®) and Clinical Outcomes: US Evidence from a Retrospective Database Analysis
por: Hennessey, James V., et al.
Publicado: (2020) -
Current evidence for the treatment of hypothyroidism with levothyroxine/levotriiodothyronine combination therapy versus levothyroxine monotherapy
por: Hennessey, James V., et al.
Publicado: (2018) -
Erratum: Formulation and characterization of orodispersible tablet of glimepiride
Publicado: (2023)